DP8

F:DP8 Germany Biotechnology
Market Cap
$34.38 Million
€33.49 Million EUR
Market Cap Rank
#25448 Global
#2784 in Germany
Share Price
€3.62
Change (1 day)
+0.56%
52-Week Range
€3.24 - €6.75
All Time High
€6.75
Categories
Companies in Germany Biotechnology
About

CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of th… Read more

DP8 (DP8) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.249x

Based on the latest financial reports, DP8 (DP8) has a cash flow conversion efficiency ratio of -0.249x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-6.47 Million) by net assets (€26.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

DP8 - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how DP8's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

DP8 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DP8 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Beammwave AB B
ST:BEAMMW-B
 		-0.048x
Blueone Card Inc
PINK:BCRD
 		0.000x
Best Agrolife Limited
NSE:BESTAGRO
 		N/A
Blue Gold Limited Class A Ordinary Shares
NASDAQ:BGL
 		-0.154x
Chia Ta World Co Ltd
TW:2033
 		0.042x
Carclo plc
PINK:CCEGF
 		-0.047x
COWELL FASHION Co.Ltd
KQ:033290
 		0.022x
DIC Holdings Construction JSC
VN:DC4
 		N/A

Annual Cash Flow Conversion Efficiency for DP8 (2021–2024)

The table below shows the annual cash flow conversion efficiency of DP8 from 2021 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €39.20 Million €-16.53 Million -0.422x +58.25%
2023-12-31 €7.38 Million €-7.45 Million -1.010x -1406.57%
2022-12-31 €-33.29 Million €-2.57 Million 0.077x +118.61%
2021-12-31 €34.91 Million €-14.50 Million -0.415x --